Verso Corporation announced today (21 September) that it has submitted to the New York Stock Exchange a business plan to demonstrate Verso's ability to achieve compliance with the NYSE's continued listing standard requiring that Verso's average market capitalization be at least $50 million over a period of 30 consecutive trading days.

As previously disclosed, on 13 August 2015, the NYSE notified Verso that it had fallen below the NYSE's average market capitalization continued listing standard. Under the NYSE's rules, Verso is allowed to submit to the NYSE a plan to demonstrate Verso's ability to achieve compliance with the average market capitalization standard within 18 months after the notification date, i.e., by 13 February 2017. Verso submitted its listing compliance plan to the NYSE earlier this morning.

Verso's plan sets forth a series of discrete, strategic actions that are designed to increase its earnings, improve its liquidity, and enhance its ability to meet its debt service obligations. These actions, which Verso already has begun implementing, consist of --

the continued successful integration of NewPage Holdings Inc., which Verso acquired in January 2015, and the planned realization of an expected $175 million of synergies to be derived from the NewPage acquisition;
the taking of market-related downtime across Verso's mill system as needed to maintain product inventories at desired levels;
production capacity reductions through the previously announced downsizing and optimization of the Androscoggin mill and the indefinite idling of the Wickliffe mill;
potential sales of certain noncore assets; and
potential new financing.

The NYSE has 45 days in which to evaluate Verso's listing compliance plan and determine whether Verso has made a reasonable demonstration of its ability to achieve compliance with the average market capitalization continued listing standard within the 18-month plan period. The NYSE either will accept the plan, at which time Verso will be subject to quarterly monitoring for compliance with the plan, or it will not accept the plan, in which case Verso will be subject to suspension by the NYSE and delisting by the Securities and Exchange Commission.

In the meantime, Verso's common stock will continue to be traded on the NYSE, subject to Verso's compliance with other NYSE continued listing requirements. In this regard, under its "abnormally low" trading price continued listing standard, the NYSE could move immediately to commence the suspension and delisting of Verso's common stock in the event that its trading price declines to $0.15 per share or below. In addition, and as previously disclosed, on 24 June 2015, the NYSE notified Verso that it had fallen below the NYSE's continued listing standard requiring that the average share price of Verso's common stock be at least $1.00 over a consecutive 30-trading-day period. To avoid suspension and delisting under this standard, Verso must bring the share price and the average share price of its common stock back to at least $1.00 within six months after the notification date, i.e., by 24 December 2015, subject to the extension of such deadline in the event that Verso undertakes to conduct a reverse stock split following its next annual stockholders meeting to be held in May 2016.